VRS
PGNX

Virginia Retirement Systems’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Virginia Retirement Systems’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-55,300
Closed -$413K – 1137
2018
Q1 		$413K Buy
55,300
+21,100
+62% +$140K 0.01% 857
2017
Q4 		$203K Sell
34,200
-2,700
-7% -$16.4K ﹤0.01% 948
2017
Q3 		$272K Sell
36,900
-8,200
-18% -$52.1K ﹤0.01% 935
2017
Q2 		$306K Buy
45,100
+17,700
+65% +$131K ﹤0.01% 938
2017
Q1 		$259K Buy
+27,400
New +$273K ﹤0.01% 1015
2016
Q3 		– Sell
-10,400
Closed -$44K – 1032
2016
Q2 		$44K Buy
+10,400
New +$50.2K ﹤0.01% 941
2015
Q4 		$292K Buy
47,600
+20,300
+74% +$133K ﹤0.01% 853
2015
Q3 		$156K Buy
+27,300
New +$209K ﹤0.01% 964

Other funds holding PGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Virginia Retirement Systems's PGNX Position: Q2 2018 in Review

Virginia Retirement Systems sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2018, closing a stake of 55,300 shares — an estimated $413K sold.

Virginia Retirement Systems first reported a position in PGNX in Q3 2015 and held it in 8 quarters. The position peaked at $413K in Q1 2018. 155 funds tracked by Wall St. Rank hold PGNX as of Q2 2018.

  • Virginia Retirement Systems reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2018 after selling out during the quarter.
  • Virginia Retirement Systems sold 55,300 Progenics Pharmaceuticals Inc shares in Q2 2018, an estimated $413K.
  • Virginia Retirement Systems first reported a position in Progenics Pharmaceuticals Inc in Q3 2015 and held it in 8 quarters.
  • Virginia Retirement Systems's Progenics Pharmaceuticals Inc position peaked at $413K in Q1 2018.
  • 155 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2018.

Based on Virginia Retirement Systems's 13F filing for Q2 2018, filed 3 Aug 2018.